Inhibition of Glycogen Synthase Kinase 3β (GSK3β) Decreases Inflammatory Responses in Brain Endothelial Cells
Authors:
- Servio H. RamirezSRServio H. Ramirez
- Aaron J. MercerAMAaron J. Mercer
- Yuri PersidskyYPYuri Persidsky
- 1 February 2010
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 176 (2) , 881-892
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injuryMicrovascular Research, 2009
- Glycogen synthase kinase 3: more than a namesakeBritish Journal of Pharmacology, 2009
- The Control of Vascular Integrity by Endothelial Cell Junctions: Molecular Basis and Pathological ImplicationsDevelopmental Cell, 2009
- Akt Regulates the Survival of Vascular Smooth Muscle Cells via Inhibition of FoxO3a and GSK3Journal of Biological Chemistry, 2008
- Phosphorylation of Claudin-5 and Occludin by Rho Kinase in Brain Endothelial CellsThe American Journal of Pathology, 2008
- Glycogen Synthase Kinase-3 (GSK3): Inflammation, Diseases, and TherapeuticsNeurochemical Research, 2006
- Novel Anti-inflammatory Role for Glycogen Synthase Kinase-3β in the Inhibition of Tumor Necrosis Factor-α- and Interleukin-1β-induced Inflammatory Gene ExpressionJournal of Biological Chemistry, 2006
- Glycogen synthase kinase 3: a drug target for CNS therapiesJournal of Neurochemistry, 2004
- Identification of a p65 Peptide That Selectively Inhibits NF-κ B Activation Induced by Various Inflammatory Stimuli and Its Role in Down-regulation of NF-κB-mediated Gene Expression and Up-regulation of ApoptosisJournal of Biological Chemistry, 2004
- Hepatocyte growth factor enhances endothelial cell barrier function and cortical cytoskeletal rearrangement: potential role of glycogen synthase kinase‐3βThe FASEB Journal, 2002